Degering, Julia
Egenlauf, Benjamin
Harutyunova, Satenik
Benjamin, Nicola
Salkić, Amina
Xanthouli, Panagiota
Eichstaedt, Christina A.
Seeger, Rebekka
Sitbon, Olivier
Grünig, Ekkehard
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 9 July 2022
Accepted: 14 December 2022
First Online: 18 January 2023
Declarations
:
: Patients provided written informed consent. The Ethics Committee of Heidelberg University had no objections against the conduct of this study (S-699/2017). The study complied with the Declaration of Helsinki in its current version.
: Not applicable.
: JD, NB, SH, AS, CAE, RS have declared that no competing interests exist. BE has received personal fees/travel fees from Janssen, MSD; OrPha Swiss GmbH, and OMT outside the submitted work. SH has received personal fees from Janssen and OMT outside the submitted work. PX has received personal fees from Bayer (MSD) and Boehringer Ingelheim outside the submitted work. OS eports grants and personal fees from Acceleron Pharmaceuticals, personal fees from AOP Orphan, grants, personal fees and nonfinancial support from Bayer, personal fees from Ferrer and Gossamer Bio, grants from GlaxoSmithKline, and grants, personal fees and nonfinancial support from Janssen and MSD, outside the submitted work. EG has received grants and personal fees from Actelion, Bayer AG, and MSD; grants from GSK, Novartis, and United Therapeutics; and personal fees from SCOPE, OrPha Swiss GmbH, and Zurich Heart House, outside the submitted work.